|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/18 | |
| A61K 39/00 | |||
| A61K 49/00 | |||
| A61K 49/16 | |||
| A61K 51/10 |
| (11) | Number of the document | 2807188 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13740871.2 |
| Date of filing the European patent application | 2013-01-25 | |
| (97) | Date of publication of the European application | 2014-12-03 |
| (45) | Date of publication and mention of the grant of the patent | 2019-09-11 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2013/023307 |
| Date | 2013-01-25 |
| (87) | Number | WO 2013/112945 |
| Date | 2013-08-01 |
| (30) | Number | Date | Country code |
| 201261591835 P | 2012-01-27 | US | |
| 201261711207 P | 2012-10-08 | US |
| (72) |
SALDANHA, Jose, GB
NIJJAR, Tarlochan S., US
|
| (73) |
Prothena Biosciences Limited,
77 Sir Rogerson`s Quay Block C Grand Canal Docklands, Dublin 2, D02 T804,
IE
|
| (54) | HUMANIZED ANTIBODIES THAT RECOGNIZE ALPHA-SYNUCLEIN |
| HUMANIZED ANTIBODIES THAT RECOGNIZE ALPHA-SYNUCLEIN |